EMBLEM Meeting at AORTIC, Durban South Africa, 21 Nov 2013

- 0 Comments

Selected EMBLEM investigators joined more than 1000 scientists from 66 countries (including 32 of the 54 countries in Africa) in Durban, South Africa to participate in the ninth biannual meeting of the African Organization for Research and Training in Cancer (AORTIC) from November 21st to 24th, 2013. Held in the historic Albert Luthuli International Convention Center, the theme of the meeting was “Cancer in Africa: Bridging Science and Humanity”.

The meeting, one of the best organized by AORTIC, included plenary and workshop sessions with up to five concurrent sessions covering epidemiology, pathogenesis, molecular studies and innovative therapeutic strategies. The meeting had a strong emphasis on capacity building, including presentations from two cohorts of the BIG CAT grants from the National Cancer …

Read more

6th ASICON – Mumbai-India, 13-15 December 2013

- 0 Comments

The 6th National Conference of AIDS Society of India (ASICON) has been held December 13th through 15th at the Palladium Hotel (former Shangri-La Hotel), a luxurious hotel located in the heart of the city, within the residential and corporate hub of Lower Parel, above the Palladium, Mumbai’s most luxurious mall.

The Conference, with contribution of 14 International and 58 national speakers articulated in 24 plenary sessions, discussion forums, workshops, abstract & poster sessions.

ASICON 2013 has been a unique opportunity for scientific update and a quality gathering of HIV care givers and scientists. Presentations and the following discussions will likely contribute to enhance the quality of HIV care and prioritize research issues in India, in particular to review and reflect …

Read more

AORTIC 2013 Durban, South Africa 21-24 November

- 0 Comments

The recent AORTIC (The African Organization for Research and Training in Cancer) Meeting held in Durban at the ICC (International Conference Center) on 21-24th November has been a relevant scientific event gathering more than 1000 scientists from 66 Countries (including 32 of the 52 countries in Africa).

The well organized meeting has been articulated in plenary and workshop sessions with up to 5 concurrent parallel sessions, spanning from epidemiological analyses to pathogenic mechanisms, biomolecular pathways, clinical data, innovative therapeutic strategies. The Meeting besides focusing on specific African oncologic issues, which needs to be properly addressed, plays a major role in the formation of a young generation of African oncologists. They will need to be ready to …

Read more

A new section on Cancer Centers in Low- and Middle-Income Countries – LMICs

- 0 Comments

As low- and middle- income countries (LMICs) continue to face health challenges from infectious disease, they are concurrently challenged by the rising burden of non-communicable diseases including cancer. Changing economics in many countries around the world have meant changes in dietary and behavioral factors, several of which are linked to increased risk for cancers.

Collaborative partnerships between a combination of low-, middle- and upper -income country cancer centers may provide a roadmap for improving cancer prevention and control capacity in low-resource settings.

In order to make information and lessons-learned about successful cancer centers and the management of cancers in LMICs more broadly available and to help re-invigorate efforts to build partnerships and provide important information for those seeking to replicate successful …

Read more

82% Efficacy of the HPV Vaccines

- 0 Comments

Cases of certain HPV strains have plunged 56 percent among females 14 years old to 19 years old since the first vaccine, Merck & Co. (MRK)’s Gardasil, was introduced in 2006, according to an article yesterday in the Journal of Infectious Diseases. The shot is 82 percent effective against the virus that can cause cervical cancer if at least one of the three doses is given.

“These are striking results and they should be a wake-up call that we need to increase vaccinations,” Thomas Frieden, director of the Centers for Disease Control and Prevention, told reporters on a conference call. “It is possible to protect a generation from cancer and we have to do it.”

A vaccine for human papillomavirus, a …

Read more

Dr Christopher Wild re-elected as Director of IARC

- 0 Comments

Lyon, France, 21 May 2013 – The International Agency for Research on Cancer (IARC) has the pleasure of announcing the re-election of Dr Christopher Wild as Director of this specialized cancer research agency of the World Health Organization (WHO). The IARC Governing Council, made up of representatives of 24 Participating States plus the Director-General of WHO, reappointed Dr Wild for a second five-year term at its annual meeting in Lyon on May 16–17, 2013.

“I have had the honour and privilege to lead IARC for five years, and I look forward to taking up the challenges posed by the markedly increasing number of cancer cases globally,” said Dr Wild. “The particularly heavy burden projected to fall on the low- and middle-income …

Read more

A Clinical Oncology Section for IAC Journal

- 0 Comments

Global Health programs are key goals of many internationally oriented Health Institutes and Organizations, and within such approach a Global Oncology program will become a major, crucial objective.

Infectious diseases are in general under control (with some emerging and re-emerging episode), life expectancy is globally increasing, and incidence as well as disease-burden of cancers (associated or not to infectious agents) will be inevitably rising. We need to develop the new clinical oncology of tomorrow and to prepare the next generation of oncologists. The aims of the section and the call for the papers is currently highlighted at the BioMed Central Blog

Helping My Wife in Her Battle With Mesothelioma: the cancer view from the patients side.

- 0 Comments

It is unusual for the IAC blog to have a post from cancer patients. However, to see the other side of the story, and to verify first hand how much effective a cancer treatment can be and how grateful patients and their families are to the scientific community, can be relevant for motivating young scientists and physicians in their daily struggle to identify pathogenic mechanisms, improve early diagnosis, discover therapeutic targets. The following post has just been received by Mr Cameron Von St. James.

November 21, 2005 will forever stand out in my memory as the day when my life fell apart. My wife, Heather, had been told that she suffered from malignant pleural mesothelioma on that day. …

Read more

A wolf can change his coat but not his character

- 0 Comments

I do not know how popular is the English version of the Latin motto Lupus pilum mutat, non mentem, in Italian, however, it is very frequently used and even with a negative or a positive meaning. The negative component is emphasized for vices, which cannot be easily abandoned; the positive component is a strong determination, motivated stubbornness.

Last week the Latin motto with the positive meaning came to my mind at the end of the Lectio Magistralis on The role of pathogens in human cancers, held on Friday April 12th at Istituto Nazionale Tumori “Fond Pascale” Naples-IT, by the Nobel Laureate Prof. Dr. Harald zur Hausen. A Nobel Laureate in Medicine (2008), retired almost 10 years ago, could be just …

Read more

EMBLEM activities

- 0 Comments
Emblem

A new short video has just been released highlighting Burkitt Lymphoma and EMBLEM activities in this area, including information on the Workshop in Mwanza last September.

The video was a collaborative project bringing local groups together to empower and recognize people who are working in the Burkitt Lymphoma area. The animation in the video was completed by students.